Lynx1 Capital Management LP, 10% Owner at Passage BIO, Inc. (PASG), bought 50,055 shares at $4.12 ($206K) on 2026-06-25, disclosed to the SEC on 2026-06-29.
Open-market purchase of $206k PASG by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| TCRX | BUY | 2025-12-23 | $218K | — | Filing → |
| NEUP | BUY | 2025-10-23 | $6.6M | — | Filing → |
| CGEM | BUY | 2025-10-21 | $2.5M | — | Filing → |